CJC-1295 no DAC

Description

CAS Number: TP2328L
Molecular Formula: C152H252N44O42
Molecular Weight: ~3367.9 g/mol
Form: Lyophilized Powder
Quantity: 5mg and 10mg
Purity: ≥ 98% (HPLC Verified)

Product Overview

CJC-1295 without DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), designed to stimulate the natural release of growth hormone (GH) from the pituitary gland. Unlike the DAC-modified version, this form of CJC-1295 has a much shorter half-life, leading to a rapid but transient pulse of GH release. This short-acting version is frequently used in studies where precise control over GH pulses is desired, often in combination with other secretagogues such as GHRPs or Ipamorelin to mimic the body’s natural growth hormone secretion rhythm.

Key areas of research include:

Acute GH and IGF-1 response studies

Short-duration pituitary stimulation models

Muscle growth and recovery investigations

Metabolic regulation and anti-aging research

Combination peptide protocols with GHRPs

Applications in Research

Exploration of short-acting GHRH analogs

Studies on pulsatile GH release dynamics

Investigations into pituitary feedback mechanisms

Synergistic applications with GHRPs and secretagogues

Storage & Handling: Store lyophilized peptide at -20°C, away from light and moisture.  Reconstitute with sterile bacteriostatic water for laboratory use.  After reconstitution, refrigerate and use within appropriate timeframes.  Avoid multiple freeze-thaw cycles.

Research Use Only – Legal Disclaimer

All Eagle Peptides products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind. By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose. Use of these materials is entirely at your own risk. Eagle Peptides assumes no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.